Skip to main content

Table 3 Quantitative summary of time lags – years from “discovery” to UK implementation

From: How long does biomedical research take? Studying the time taken between biomedical and health research and its translation into products, policy, and practice

Case study topics

Overall time lag in years from “discovery” to implementation (ie not always counting some initial discovery time)

Field: cardiovascular disease (CVD) or mental health (MH)

Intervention type

Lag from “discovery” to start of first phase I trial or human research

Lag from phase I to start of first phase II trial

Lag from phase II to start of first phase III trial

Lag from start of phase III or human research to first research review and synthesis

Lag from research review and synthesis to first policy statement

Lag from policy statement to implementation

1: Amlodipine

23 years

CVD

Pharmaceutical

3

1

2

10

7

0

2: Olanzapine

20 years

MH

Pharmaceutical

4

2

5

5

4

0

3: Abdominal aortic aneurysm screening

26 years

CVD

Screening

0

1

5

14

5

1

4a: Smoking reduction: Evidence on passive smoking to widespread bans

39 years

CVD

Public health

14

n/a

n/a

5

19

1

4b: Smoking reduction: Link between smoking and ill health to ban on advertising (Top TV ban, Bottom widespread ban)

26 years

CVD

Public health

12

n/a

n/a

6

8

0

54 years

30

6

5: Cognitive behavioural therapy and depression

49 years

MH

Psychosocial

15

n/a

n/a

12

12

10

6: Cognitive behavioural therapy and schizophrenia

48 years

MH

Psychosocial

17

n/a

n/a

23

0

8

7: Early intervention for schizophrenia

18 years

MH

Service configuration/Health service delivery

6

n/a

n/a

Reviews after implementation

7

5